Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Objective: A lack of persistence to antiosteoporosis drugs (AOM) has been reported. In addition, AOM treatments may be compromised by different recent safety alerts. We aimed to estimate the incidence and persistence of AOM use in Spanish primary care.

More information Original publication

DOI

10.1007/s00198-016-3530-x

Type

Conference paper

Publisher

Springer Verlag

Publication Date

2016-05-17T00:00:00+00:00

Volume

27